These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34366834)

  • 1.
    Salles PF; Perce-da-Silva DS; Rossi AD; Raposo LR; Ramirez Ramirez AD; Pereira Bastos OM; Pratt-Riccio LR; Cassiano GC; Baptista ARS; Cardoso CC; Banic DM; Machado RLD
    Front Pharmacol; 2021; 12():542342. PubMed ID: 34366834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of the CYP2D6 enzymatic activity based on investigating of the CYP2D6 genotypes around the vivax malaria patients in Yunnan Province, China.
    Dong Y; Huang H; Deng Y; Xu Y; Chen M; Liu Y; Zhang C
    Malar J; 2021 Nov; 20(1):448. PubMed ID: 34823523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2D6 activity and the risk of recurrence of Plasmodium vivax malaria in the Brazilian Amazon: a prospective cohort study.
    Brasil LW; Rodrigues-Soares F; Santoro AB; Almeida ACG; Kühn A; Ramasawmy R; Lacerda MVG; Monteiro WM; Suarez-Kurtz G
    Malar J; 2018 Feb; 17(1):57. PubMed ID: 29390987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Insights into Plasmodium vivax Therapeutic Failure: CYP2D6 Activity and Time of Exposure to Malaria Modulate the Risk of Recurrence.
    Silvino ACR; Kano FS; Costa MA; Fontes CJF; Soares IS; de Brito CFA; Carvalho LH; Sousa TN
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32122891
    [No Abstract]   [Full Text] [Related]  

  • 5. The association of CYP2D6 gene polymorphisms in the full-length coding region with higher recurrence rate of vivax malaria in Yunnan Province, China.
    Huang H; Dong Y; Xu Y; Deng Y; Zhang C; Liu S; Chen M; Liu Y
    Malar J; 2021 Mar; 20(1):160. PubMed ID: 33743705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study.
    Puaprasert K; Chu C; Saralamba N; Day NPJ; Nosten F; White NJ; Dondorp AM; Imwong M
    Malar J; 2018 Nov; 17(1):427. PubMed ID: 30442143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of polymorphisms of CYP2D6 and CYP2C9 with early onset severe pre-eclampsia and response to labetalol therapy.
    Sun CJ; Li L; Li XY; Zhang WY; Liu XW
    Arch Gynecol Obstet; 2018 Jul; 298(1):125-132. PubMed ID: 29789925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing and Evaluating the HRM Technique for Identifying Cytochrome P450 2D6 Polymorphisms.
    Lu HC; Chang YS; Chang CC; Lin CH; Chang JG
    J Clin Lab Anal; 2015 May; 29(3):220-5. PubMed ID: 24798984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of the HFE C282Y and H63D polymorphisms in Brazilian malaria patients and blood donors from the Amazon region.
    Torres FR; Souza-Neiras WC; D'Almeida Couto AA; D'Almeida Couto VS; Cavasini CE; Rossit AR; Machado RL; Bonini-Domingos CR
    Genet Mol Res; 2008 Jan; 7(1):60-4. PubMed ID: 18273820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax Malaria.
    Baird JK; Louisa M; Noviyanti R; Ekawati L; Elyazar I; Subekti D; Chand K; Gayatri A; Instiaty ; Soebianto S; Crenna-Darusallam C; Djoko D; Hasto BD; Meriyenes D; Wesche D; Nelwan EJ; Sutanto I; Sudoyo H; Setiabudy R
    JAMA Netw Open; 2018 Aug; 1(4):e181449. PubMed ID: 30646129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of MAO-A and CYP450 on primaquine metabolism in healthy volunteers.
    Ariffin NM; Islahudin F; Kumolosasi E; Makmor-Bakry M
    Parasitol Res; 2019 Mar; 118(3):1011-1018. PubMed ID: 30706164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 2D6 profiles and their relationship with outcomes of primaquine anti-relapse therapy in Australian Defence Force personnel deployed to Papua New Guinea and East Timor.
    Chen N; Dowd S; Gatton ML; Auliff A; Edstein MD; Cheng Q
    Malar J; 2019 Apr; 18(1):140. PubMed ID: 30999967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of trem-1 gene polymorphisms on cytokine levels during malaria by Plasmodium vivax in a frontier area of the Brazilian Amazon.
    de Jesus MCS; Cerilo-Filho M; Ramirez ADR; Menezes RAO; Gomes MSM; Cassiano GC; Gurgel RQ; Silva JRS; Moura TR; Pratt-Riccio LR; Baptista ARS; Storti-Melo LM; Machado RLD
    Cytokine; 2023 Sep; 169():156264. PubMed ID: 37327529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function.
    Martin Ramírez A; Lombardia González C; Soler Maniega T; Gutierrez Liarte Á; Domingo García D; Lanza Suárez M; Bernal Fernández MJ; Rubio JM
    Malar J; 2020 Jul; 19(1):259. PubMed ID: 32680522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence for association of the CD40, CD40L and BLYS polymorphisms, B-cell co-stimulatory molecules, with Brazilian endemic Plasmodium vivax malaria.
    Capobianco MP; Cassiano GC; Furini AA; Storti-Melo LM; Pavarino EC; Galbiatti AL; Fraga VD; Conceição LM; Couto VS; Couto AA; Machado RL
    Trans R Soc Trop Med Hyg; 2013 Jun; 107(6):377-83. PubMed ID: 23604864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of the CYP2D6*10 (C100T), *4 (G1846A), and *14 (G1758A) alleles among Iranians of different ethnicities.
    Bagheri A; Kamalidehghan B; Haghshenas M; Azadfar P; Akbari L; Sangtarash MH; Vejdandoust F; Ahmadipour F; Meng GY; Houshmand M
    Drug Des Devel Ther; 2015; 9():2627-34. PubMed ID: 25999696
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Mehlotra RK; Gaedigk A; Howes RE; Rakotomanga TA; Ratsimbasoa AC; Zimmerman PA
    Front Pharmacol; 2021; 12():654054. PubMed ID: 33959023
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasmodium vivax mdr1 genotypes in isolates from successfully cured patients living in endemic and non-endemic Brazilian areas.
    Gomes LR; Almeida-de-Oliveira NK; de Lavigne AR; de Lima SR; de Pina-Costa A; Brasil P; Daniel-Ribeiro CT; Ménard D; Ferreira-da-Cruz Mde F
    Malar J; 2016 Feb; 15():96. PubMed ID: 26887935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Plasmodium vivax malaria and antimalarial treatment on cytochrome P450 activity in Brazilian patients.
    Almeida AC; Elias ABR; Marques MP; de Melo GC; da Costa AG; Figueiredo EFG; Brasil LW; Rodrigues-Soares F; Monteiro WM; de Lacerda MVG; Lanchote VL; Suarez-Kurtz G
    Br J Clin Pharmacol; 2021 Apr; 87(4):1859-1868. PubMed ID: 32997351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TOLLIP gene variant is associated with Plasmodium vivax malaria in the Brazilian Amazon.
    Brasil LW; Barbosa LR; de Araujo FJ; da Costa AG; da Silva LD; Pinheiro SK; de Almeida AC; Kuhn A; Vitor-Silva S; de Melo GC; Monteiro WM; de Lacerda MV; Ramasawmy R
    Malar J; 2017 Mar; 16(1):116. PubMed ID: 28288644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.